Re: JDRF - Advocate For What & Whom?

[ Follow-Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Posted by Elaine on 19:00:52 2010/01/19

In Reply to: Re: $7 billion company gets $ from JDRF donors posted by Mike Bowen

Your browser does not support inline frames, or it has been configured incorrectly. If page does not display on your browser, please <a href="http://www.diabeteshealth.com/read/2006/07/01/4834/advocate-for-what-and-whom/">CLICK HERE</a>. Advocate For What & Whom? - Diabetes Health My Account | Sitemap | Advanced Search |-- Subscribe | Contact Us | Donate Search Home Charts Forums Digital Edition TV Community Type 2 Issues Type 1 Issues Kids & Teens Professional Issues Beginners Pre-Diabetes Events Health History Camps for Kids International Online Resources Dating Pets Type 1.5 Issues All Sections Products Product Directory Charts Syringes Insulin Pumps Meters Pens Software CGMs Medical ID Jewelry Lancing Devices Carrying Cases Infusion Sets Books Pen Needles All Sections Complications & Care Heart Care & Heart Disease Low Blood Sugar Foot Care Kidney Care (Nephropathy) Nerve Care (Neuropathy) Sexual Issues Eye Care (Retinopathy) Hypoglycemia Unawareness Lipid Problems Depression Skin Care Wound Care Oral Health Gastroparesis (Digestion Problems) Celiac Disease All Sections Food Recipes Diets Vitamins Food News Nutrition Advice Low Carb Glycemic Index & Carb Counting Low Calorie & Low Fat Supplements Beverages Desserts Herbs Sugar & Sweeteners Dinner Lunch All Sections Columns Cartoons & eCards Personal Stories Letters to the Editor My Own Injection Inspiration Book Reviews Heroes CDE of the Month Making a Difference Doctors & Nurses Motivation After All These Years Love and Diabetes All Sections Medications Insulin Type 2 Medications Pharmacy Metformin Lantus Byetta Animal Insulin Actos Januvia Symlin Apidra Onglyza Voglibose Victoza All Sections Research Nutrition Research Islet & Pancreas Transplant Medications Research Other Lab Tests Artificial Pancreas Health Research The Cure Beta Cells New Cure Research Case Studies All Sections Fitness Exercise Weight Loss Bariatric Surgery Success Stories Amphetamines All Sections Monitoring Blood Sugar A1c Test Noninvasive Monitors Laboratory Tests Urine Test All Sections Health Care Health Insurance Hospital Care Complementary Therapies Endocrinology Smoking Physical Therapy CDE All Sections Psychology Support Groups Living with Diabetes Adolescent Boys Adolescent Girls Women's Issues Teenagers Men's Issues Insulin Omission All Sections Legal Discrimination Government & Policy Politics Drivers License & Pilot License Driving Lobbying 504 Plan in School All Sections Celebrities Nick Jonas Jay Hewitt Scott Dunton Elliott Yamin All Sections Pregnancy Childbirth Breastfeeding Gestational Diabetes All Sections About Us About Us Publisher's Letter Advertising Contact Us Press Room Submission Guidelines Privacy Policy Help ADVERTISEMENT function fbs_click() {u=location.href;t=document.title;window.open('<a style="font-weight:normal" href="http://www.facebook.com/sharer.php?u='+encodeURIComponent(u">http://www.facebook.com/sharer.php?u='+encodeURIComponent(u</a>)+'&t='+encodeURIComponent(t),'sharer','toolbar=0,status=0,width=626,height=436');return false;} function click_on_select() { if (document.subscribeform.type.selectedIndex == 0) { document.subscribeform.elements[3].checked = true; document.subscribeform.elements[4].checked = false; } else if (document.subscribeform.type.selectedIndex == 1) { document.subscribeform.elements[4].checked = true; document.subscribeform.elements[3].checked = false; } else { document.subscribeform.elements[3].checked = true; document.subscribeform.elements[4].checked = false; } } -- See What's Inside… Insulin Insulin Pens Insulin Pen Needles Insulin Pumps Infusion Sets Continuous Glucose Monitors Blood Glucose Meters Type 2 Medications Lancing Devices Syringes Fast-Acting Products Sugar-Free Foods Mail Order Companies View Diabetes Health Magazine For Free Online You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want. Click Here To View Free Subscription to Diabetes Health Professional If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you. Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients. Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options. Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients. ADVERTISEMENT Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox. As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are! Email Address: Area of Interest: Consumer Professional How To Change Your Newsletter Email… You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive Then enter your new email address in the above form and click "Subscribe" ADVERTISEMENT Latest Popular Top Rated Latest General Articles AACE Calls for New Standards for Safer Insulin Pump Use The Diabetes Exercise and Sports Association Conference An Update - and a Plea From Tour Now & Then Animas Corporation expands product line with introduction of inset™ 30 Advocate For What & Whom? What’s New? Follow the Money IDF Aiming for a Worldwide Resolution on Diabetes Shouting Out About Federal Funding for Medical Research Letter to the Editor Popular General Articles The Dawn Phenominon & The Symogi Effect, By Mr. Metabolism Finally Something Noninvasive Sorbitol’s Laxative Effect Might Cause Abdominal Problems Questions and Answers What Lies Behind the High Cost of Diabetes Frozen Shoulder—11% Of People With Diabetes Get It, Readers Want Answers The Healing Touch - A Massage a Day Keeps BGs at Bay Questions and Answers Oh, the Irony—Does an Insulin Maker’s Schizophrenia Drug Cause Diabetes? Why Are My Morning Sugars Over 300? Highly Recommended General Articles Frozen Shoulder—11% Of People With Diabetes Get It, Readers Want Answers AACE Calls for New Standards for Safer Insulin Pump Use Diabetes in Sudan Increases By 71% Animas Corporation expands product line with introduction of inset™ 30 Free Diabetes Eduction Video Will the Real Project Cure Please Stand Up? Caution: Don't Get Caught with Ketones Not Enough Potassium Therapeutic Massage and Diabetes Dyslipidemia: What Is It? General Archives Browse the General Archives Subscribe to the General RSS Feed Print | Email | Share | Comments (0) Email to a Friend Send a link to this page to your friends and colleagues. Your Name: Your Email: Recipient's Name: Recipient's Email: Close Advocate For What & Whom? (There’s More To JDRF Than Meets The Eye!) Bill Vosburgh Jul 1, 2006 I just discovered your May 2005 article, “ Why Did the JDRF Try to Discredit Cure Research? ” That, and lingering resentment over my own futile correspondence with Van Etten and Ahearn, inspired me to dig deeper into some points you made and some reasonable suspicions your article aroused. Neil Munro’s 1/22/05 article in National Journal “Charitable Choices” is another informative article about JDRF’s campaign to block Dr. Faustman’s research. (See Autoimmune Disease Research Foundation’s website, www.cureautoimmunity.org ) For my contribution to the cure , I’d like to see Diabetes Health and other interested media you might contact expose another facet of JDRF’s motivation and conduct so that uninformed JDRF donors can re-direct their contributions to those truly seeking a cure. On 7/9/03, JDRF proclaimed a “vital new development in JDRF’s research strategy.” This was a radical departure from JDRF’s much ballyhooed “not-for-profit” status. Intending to mislead, JDRF announced “an increased effort (emphasis added) to partner with for-profit entities.” This has apparently been conducted for sometime by JDRF’s for-profit arm using the acronym IDDP (Industry Discovery & Development Partnerships Funding). (Easiest access to this JDRF web page is via Google: “JDRF for-profit”) The smell of JDRF’s for-profit arm is also on the nonprofit 2004 IRS form 990 posted on JDRF’s website. Line 78a says JDRF had unrelated business income of $1,000 or more and a form 990-T was filed. However, JDRF did not disclose the for-profit information reported on form 990-T. Since JDRF funds research for many patentable drugs to treat complications, their economic benefits from such drugs would be reported by JDRF’s for-profit arm. The source and amount of that income, which may create conflicts, should be of interest to JDRF supporters. The for-profit information might convince these people why every dollar JDRF gets is used to block, not find, the cure. The question of expenses reported on the concealed for-profit return is just as intriguing as the income. Nonprofit (tax-exempt) entities do not pay taxes on their income from contributions so they get no tax benefit by deducting expenses. Therefore, effective tax planning requires that as many deductible expenses as required (limited only by the fertile imagination of institutional lawyers and accountants), should be reported on the for-profit arm’s return where expenses will offset some or all of the taxable income (“profit”). So, I wonder. Did JDRF officers get more than the salaries & benefits supporters see on nonprofit JDRF’s 2004 return that are reported on JDRF’s for-profit arm’s concealed return? Did former Pres & CEO Van Etten get more than $610,740? Did Dr. Insel get more than $542,921? Or did lawyer Robert German get more than his publicly reported “0” salary? The same question exists for Chief Scientific Ofcr Dr. Robert Goldstein ($349,560) and VP Strategic Communications Bill Ahearn ($281,685). Since this group has demonstrated capacity to pervert the goals and fervent hopes of so many who rely on JDRF, it seems reasonable to suspect yet undiscovered chicanery. The diabetic community was simply naive to imagine there would not be a fatal conflict between JDRF’s discovery and development of partnerships, and our fruitless hope for discovery of the cure. Which “partners” influence what research should be funded? My second point is that the purpose and function of lawyers in corporations and other institutions is widely unappreciated or misunderstood. Neil Munro’s “Charitable Choices” provides a vivid example of the duplicity, deceptive rationalization, lack of integrity and deviousness that lawyers are notorious for. JDRF’s chairman of the board, lawyer Robert German, was asked about conflicts between researchers’ intense professional and personal rivalries along with their interests in scientific knowledge or development of products for the diabetes market and lay members’ goal for a cure. German said, “I would not tolerate anything going on, other than what’s contributing to a cure.” Since the cause of T1D is a defective, autoreactive immune system that attacks the diabetic’s pancreatic beta cells, how about curing the disease by first finding then removing the cause? I hope German’s future rationalizing is recorded when his diabetic son asks why German tolerated JDRF hogging research money just to blow it on research here and abroad for embryonic stem cells, islet transplant ation and more recently, continuous sensors for closed-loop pumps. Although I’m not a lawyer, I can distinguish between “cure” and “treatment” without a legal opinion. Will those great embryonic stem cells and islet transplants fare any better than the body’s own insulin producing cells against an uncured immune system defect? How does partnering with insulin pump companies on continuous sensors ”cure” diabetes or even normalize blood glucose? Will insulin injected subcutaneously with a closed-loop pump normalize b.g. regardless of the pump program’s algorithm? Please consider that sub-Q insulin has a duration of 3.5-4 hours versus I.V. insulin’s duration (not peak) of 50 minutes. A normal pancreas infuses insulin into the liver’s portal vein. That is what keeps blood glucose from soaring after meals. Insulin is released at the start of meals and circulates throughout the blood stream in 7 seconds. It does the same when a bolus is taken I.V. But all the sub-Q insulin doesn’t even get into the blood stream for hours and then still has to react with muscle and other tissue before blood glucose, that is elevated by then, can begin to drop. The only thing diabetics have seen from JDRF for many years is an obscene violation of the public trust. After 36 years, billions of dollars, executives paid in excess of half a million a year, and now a real possible cure ready for human trials (that JDRF refused to fund), I’m under impressed with continued funding for fruit-fly and zebra-fish research. Your article quotes the 4/8/05 letter from former JDRF president and CEO Peter Van Etten. In that, Van Etten said the decision not to fund research by Drs. Faustman and Nathan as well as many other regeneration proposals, “reflects a change in JDRF’s significant focus on, or ongoing support for, regeneration science.” I suggest the reason for this change in JDRF’s funding policy was that Faustman proposed human trials. That would be a serious threat, and could cause an abrupt end, to fraudulent fund raising under the guise of “cure” research but used instead to research profitable treatment drugs for the pharmaceutical industry. The pharmaceutical industry’s disincentive for cure research was presented in your 10/03 cover story, “ Curing a profitable disease is not a good business decision .” I would add that curing is not a good business decision for professional fund raisers, either. The only research I’ve heard of that has taken the intuitively obvious approach of trying to cure diabetes by first finding the cause, then removing the cause to see if beta cells will regenerate, and is FDA approved for human trials, is the unique research being conducted at Massachusetts General Hospital. But JDRF denied funds to support this research not just once but three times. While Type 1 diabetics may not have a choice whether to patronize insulin and test-strip manufacturers, directing our time, effort or money to an organization that directs those resources away from a cure is idiotic if not suicidal. I hope enough people who are truly concerned about curing diabetes will send contributions directly to the researcher of their choice. Diabetics have to stop funding the morally corrupt alliance between professional fund raisers and career researchers bent on perpetual fund raising for perpetual research that is blocking the cure. For those interested, contributions for Dr. Faustman’s type-1 diabetes research can be so noted and sent to Massachusetts General Hospital East, c/o Ms. Lynne Murphy, Administrative Assistant, Building 149, 13th Street, Room 3601, Charlestown, MA 02129. Categories: General Facebook MySpace Digg Recommend this : Not at all Somewhat Moderately Highly Very Highly Average Rating: You May Also Be Interested In... Click Here To View Or Post Comments Jul 1, 2006 - Home | Charts | Forums | Digital Edition | TV | Subscribe | Contact Us | Donate | Sitemap ©1991-2010 Diabetes Health

Click here to visit inline page

Follow Ups:

Re: Why Did JDRF Try to Discredit Cure Research? - Elaine 19:02:42 2010/01/19 (0)

Post a Followup

[ Follow Ups ] [ Post Followup ] [ The Islet Foundation Public Message Forum ]

Name:
E-Mail: (Optional)
Subject:
Comments:
Link URL: (Optional)
Link Title:
Image URL: (Optional)